Skip to main content
Top
Published in: Calcified Tissue International 1/2016

01-07-2016 | Original Research

Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/ß-Catenin Pathway

Authors: Dai Deng, Zongli Diao, Xue Han, Wenhu Liu

Published in: Calcified Tissue International | Issue 1/2016

Login to get access

Abstract

Vascular calcification (VC) is highly prevalent and represents a major cardiovascular risk factor in chronic kidney disease (CKD) patients. High phosphate (HP) levels are strongly associated with VC in this population. Secreted frizzled-related protein 5 (SFRP5), one of the inhibitors of the Wnt pathway, is a known anti-inflammatory adipokine with a positive effect on metabolic and cardiovascular diseases, in addition to its anticancer potency. However, the role of SFRP5 in the pathophysiology of VC is unclear. This work aimed to study the mechanism of action of SFRP5 on the progression of HP-induced VC, which resembles the CKD-related VC, through its direct effect on vascular smooth muscle cells (VSMCs) in vitro. Addition of SFRP5 significantly inhibited HP-induced calcification of VSMCs as determined by Alizarin red staining and calcium content. The inhibitory effect of SFRP5 on calcification of VSMCs was due to the suppression of HP-induced expression of calcification and osteoblastic markers. In addition, SFRP5 abrogated HP-induced activation of the Wnt/ß-catenin pathway, which plays a key role in the pathogenesis of VC. The specificity of SFRP5 for the inhibition of calcification of VSMCs was confirmed by using a neutralizing antibody to SFRP5. Our results suggest that SFRP5 inhibits HP-induced calcification of VSMCs by inhibiting the expression of calcification and osteoblastic markers, as well as the Wnt/ß-catenin pathway. Our study may indicate that SFRP5 is a potential therapeutic agent in calcification of VSMCs.
Literature
1.
go back to reference Eknoyan G, Lameire N, Barsoum R et al (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310–1314CrossRefPubMed Eknoyan G, Lameire N, Barsoum R et al (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310–1314CrossRefPubMed
2.
go back to reference Briet M, Burns KD (2012) Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. ClinSci 123:399–416 Briet M, Burns KD (2012) Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. ClinSci 123:399–416
3.
go back to reference Liabeuf S, Desjardins L, Diouf M et al (2015) The addition of vascular calcification scores to traditional risk factors improves cardiovascular risk assessment in patients with chronic kidney disease. PLoS ONE 10:e0131707CrossRefPubMedPubMedCentral Liabeuf S, Desjardins L, Diouf M et al (2015) The addition of vascular calcification scores to traditional risk factors improves cardiovascular risk assessment in patients with chronic kidney disease. PLoS ONE 10:e0131707CrossRefPubMedPubMedCentral
4.
go back to reference Covic A, Kanbay M, Voroneanu L et al (2010) Vascular calcification in chronic kidney disease. ClinSci 119:111–121 Covic A, Kanbay M, Voroneanu L et al (2010) Vascular calcification in chronic kidney disease. ClinSci 119:111–121
5.
go back to reference Moe SM, Chen NX (2008) Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19:213–216CrossRefPubMed Moe SM, Chen NX (2008) Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19:213–216CrossRefPubMed
6.
7.
go back to reference Palmer SC, Hayen A, Macaskill P et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119–1127CrossRefPubMed Palmer SC, Hayen A, Macaskill P et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119–1127CrossRefPubMed
8.
go back to reference El-Abbadi MM, Pai AS et al (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75:1297–1307CrossRefPubMedPubMedCentral El-Abbadi MM, Pai AS et al (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75:1297–1307CrossRefPubMedPubMedCentral
9.
go back to reference Yao L, Sun YT, Sun W et al (2015) High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease. Am J Nephrol 41:28–36CrossRefPubMed Yao L, Sun YT, Sun W et al (2015) High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease. Am J Nephrol 41:28–36CrossRefPubMed
10.
go back to reference Shao JS, Aly ZA, Lai CF et al (2007) Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci 1117:40–50CrossRefPubMed Shao JS, Aly ZA, Lai CF et al (2007) Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci 1117:40–50CrossRefPubMed
11.
go back to reference Gough NR (2012) Focus issue: Wnt and β-catenin signaling in development and disease. Sci Signal 5:eg2PubMed Gough NR (2012) Focus issue: Wnt and β-catenin signaling in development and disease. Sci Signal 5:eg2PubMed
12.
go back to reference Johnson ML, Kamel MA (2007) The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19:213–216CrossRef Johnson ML, Kamel MA (2007) The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19:213–216CrossRef
13.
go back to reference Martínez-Moreno JM, Muñoz-Castañeda JR, Herencia C et al (2012) In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. Am J Physiol Renal Physiol 303:F1136–F1144CrossRefPubMed Martínez-Moreno JM, Muñoz-Castañeda JR, Herencia C et al (2012) In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. Am J Physiol Renal Physiol 303:F1136–F1144CrossRefPubMed
14.
go back to reference Montes de Oca A, Guerrero F, Martinez-Moreno JM (2014) Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenice transformation of vascular smooth muscle cells. PLoS ONE 9(2):e89525CrossRefPubMedPubMedCentral Montes de Oca A, Guerrero F, Martinez-Moreno JM (2014) Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenice transformation of vascular smooth muscle cells. PLoS ONE 9(2):e89525CrossRefPubMedPubMedCentral
15.
go back to reference Ouchi N, Higuchi A, Ohashi K et al (2010) Sfrp5 is an anti-inflammatory adipokine thatmodulates metabolicdysfunction in obesity. Science 329:454–457CrossRefPubMedPubMedCentral Ouchi N, Higuchi A, Ohashi K et al (2010) Sfrp5 is an anti-inflammatory adipokine thatmodulates metabolicdysfunction in obesity. Science 329:454–457CrossRefPubMedPubMedCentral
16.
go back to reference Li Y, Rankin SA, Sinner D et al (2008) Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling. Genes Dev 22:3050–3063CrossRefPubMedPubMedCentral Li Y, Rankin SA, Sinner D et al (2008) Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling. Genes Dev 22:3050–3063CrossRefPubMedPubMedCentral
17.
go back to reference Wang R, Hong J, Lin R et al (2014) SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. J Mol Endocrinol 53:405–415CrossRefPubMed Wang R, Hong J, Lin R et al (2014) SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. J Mol Endocrinol 53:405–415CrossRefPubMed
18.
go back to reference Jaikanth C, Gurumurthy P, Indhumathi T et al (2014) Emergence of sfrp5 as a pleiotropic adipocytokine and its association with wnt signaling. Minerva Endocrinol July 8[Epub ahead of print] Jaikanth C, Gurumurthy P, Indhumathi T et al (2014) Emergence of sfrp5 as a pleiotropic adipocytokine and its association with wnt signaling. Minerva Endocrinol July 8[Epub ahead of print]
19.
go back to reference Román-García P, Carrillo-López N, Fernández-Martín JL et al (2010) High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 46:121–128CrossRefPubMed Román-García P, Carrillo-López N, Fernández-Martín JL et al (2010) High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 46:121–128CrossRefPubMed
20.
go back to reference Miyoshi T, Doi M, Usui S et al (2014) Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. Atherosclerosis 233:454–459CrossRefPubMed Miyoshi T, Doi M, Usui S et al (2014) Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. Atherosclerosis 233:454–459CrossRefPubMed
21.
go back to reference Jin X, Guo B, Yan J et al (2015) Angiotensin IIincreases secreted frizzled-related protein 5(sFRP5) expression through AT1 receptor/Rho/Rock1/JNK signaling in cardiomyocytes. Mol Cell Biochem 408:215–222CrossRefPubMed Jin X, Guo B, Yan J et al (2015) Angiotensin IIincreases secreted frizzled-related protein 5(sFRP5) expression through AT1 receptor/Rho/Rock1/JNK signaling in cardiomyocytes. Mol Cell Biochem 408:215–222CrossRefPubMed
23.
go back to reference Rong S, Zhao X, Jin X et al (2014) Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/β-catenin pathway. Cell Physiol Biochem 34:2049–2060CrossRefPubMed Rong S, Zhao X, Jin X et al (2014) Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/β-catenin pathway. Cell Physiol Biochem 34:2049–2060CrossRefPubMed
24.
go back to reference Li X, Yang HY, Giachelli CM (2008) BMP-2 promotes phosphate uptake, phenotypicmodulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199:271–277CrossRefPubMedPubMedCentral Li X, Yang HY, Giachelli CM (2008) BMP-2 promotes phosphate uptake, phenotypicmodulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199:271–277CrossRefPubMedPubMedCentral
25.
go back to reference Herencia C, Rodríguez-Ortiz ME, Muñoz-Castañeda JR et al (2015) Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx. Eur J Clin Invest 45:1129–1144CrossRefPubMed Herencia C, Rodríguez-Ortiz ME, Muñoz-Castañeda JR et al (2015) Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx. Eur J Clin Invest 45:1129–1144CrossRefPubMed
26.
go back to reference Lee KM, Kang HA, Park M et al (2012) Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway. Biochem Biophys Res Commun 428:50–55CrossRefPubMed Lee KM, Kang HA, Park M et al (2012) Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway. Biochem Biophys Res Commun 428:50–55CrossRefPubMed
27.
go back to reference Chatani N, Kamada Y, Kizu T et al (2015) Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int 35:2017–2026CrossRefPubMed Chatani N, Kamada Y, Kizu T et al (2015) Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int 35:2017–2026CrossRefPubMed
28.
go back to reference Carstensen M, Wiza C, Röhrig K et al (2014) Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells. PLoS ONE 9:e85906CrossRefPubMedPubMedCentral Carstensen M, Wiza C, Röhrig K et al (2014) Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells. PLoS ONE 9:e85906CrossRefPubMedPubMedCentral
29.
go back to reference Mikhaylova L, Malmquist J, Nurminskaya M et al (2007) Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif Tissue Int 81:372–381CrossRefPubMed Mikhaylova L, Malmquist J, Nurminskaya M et al (2007) Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif Tissue Int 81:372–381CrossRefPubMed
30.
go back to reference Mori H, Prestwich TC, Reid MA et al (2012) Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest 122:2405–2416CrossRefPubMedPubMedCentral Mori H, Prestwich TC, Reid MA et al (2012) Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest 122:2405–2416CrossRefPubMedPubMedCentral
31.
go back to reference Bovolenta P, Esteve P, Ruiz JM et al (2008) Beyond Wnt inhibition: new functions of secretedFrizzled-related proteins in development and disease. J Cell Sci 121:737–746CrossRefPubMed Bovolenta P, Esteve P, Ruiz JM et al (2008) Beyond Wnt inhibition: new functions of secretedFrizzled-related proteins in development and disease. J Cell Sci 121:737–746CrossRefPubMed
32.
go back to reference Stuckenholz C, Lu L, Thakur PC et al (2013) Sfrp5 modulates both Wnt and BMP signaling andregulates gastrointestinal organogensis in the Zebrafish, Daniorerio. PLoS One 8:e62470CrossRefPubMedPubMedCentral Stuckenholz C, Lu L, Thakur PC et al (2013) Sfrp5 modulates both Wnt and BMP signaling andregulates gastrointestinal organogensis in the Zebrafish, Daniorerio. PLoS One 8:e62470CrossRefPubMedPubMedCentral
Metadata
Title
Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/ß-Catenin Pathway
Authors
Dai Deng
Zongli Diao
Xue Han
Wenhu Liu
Publication date
01-07-2016
Publisher
Springer US
Published in
Calcified Tissue International / Issue 1/2016
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-016-0117-7

Other articles of this Issue 1/2016

Calcified Tissue International 1/2016 Go to the issue